We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+22.97%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$8.66M
(+3.6%)
Cap. Flow
-$21.9M
Cap. Flow
% of AUM
-8.9%
Top 10 Holdings %
Top 10 Hldgs %
58.46%
Holding
128
New
9
Increased
13
Reduced
12
Closed
14
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNM.PRP
Federal National Mortgage Association Non Cum Pfd Ser P
FNM.PRP
|
+$2.15M |
| 2 |
ChemoCentryx, Inc.
CCXI
|
+$1.77M |
| 3 |
FNM.PRF
FANNIE MAE VAR RT PFD SR F
FNM.PRF
|
+$1.51M |
| 4 |
Alkermes
ALKS
|
+$856K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$793K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSG
The Stars Group Inc.
TSG
|
+$6.62M |
| 2 |
Apollo Global Management
APO
|
+$3.64M |
| 3 |
LKQ Corp
LKQ
|
+$3.4M |
| 4 |
Delta Air Lines
DAL
|
+$3.31M |
| 5 |
Community Healthcare Trust
CHCT
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.43% |
| 2 | Industrials | 15.49% |
| 3 | Financials | 10.94% |
| 4 | Communication Services | 7.73% |
| 5 | Energy | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Ligand Pharmaceuticals
LGND
$5.91B
| $36.8M | 14.92% |
565,925
| – | – |
2013 Q2
26 quarters
|
|
2
FTAI Aviation
FTAI
$16.9B
| $17.4M | 7.04% |
1,040,444
| – | – |
2018 Q3
5 quarters
|
|
3
DELISTED
Stericycle Inc
SRCL
| $17.2M | 6.96% |
269,083
-45,000
| -14% | -$2.66M |
2019 Q1
3 quarters
|
|
4
Upland Software
UPLD
$9.73M
| $15.6M | 6.34% |
43,800
| – | – |
2017 Q4
8 quarters
|
|
|
5
Apollo Global Management
APO
$65.8B
| $11.3M | 4.59% |
237,500
-85,208
| -26% | -$3.64M |
2017 Q2
10 quarters
|
|
6
Alphabet (Google) Class C
GOOG
$4.12T
| $10.6M | 4.28% |
158,000
| – | – |
2019 Q1
3 quarters
|
|
7
FS KKR Capital
FSK
$2.86B
| $9.36M | 3.79% |
381,750
| – | – |
2019 Q3
1 quarter
|
|
8
MPLX
MPLX
$58.6B
| $9.33M | 3.78% |
366,558
| – | – |
2018 Q1
7 quarters
|
|
9
Brightstar Lottery PLC
BRSL
$1.76B
| $9.09M | 3.69% |
607,500
| – | – |
2019 Q1
3 quarters
|
|
10
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $7.54M | 3.05% |
175,900
| – | – |
2014 Q2
22 quarters
|
|
11
Calumet Specialty Products
CLMT
$5.02B
| $7.37M | 2.99% |
2,020,000
| – | – |
2018 Q1
7 quarters
|
|
|
12
LKQ Corp
LKQ
$5.65B
| $7.14M | 2.89% |
200,000
-100,000
| -33% | -$3.4M |
2018 Q2
6 quarters
|
|
|
TSG
13
DELISTED
The Stars Group Inc.
TSG
| $6.52M | 2.64% |
250,000
-295,800
| -54% | -$6.62M |
2018 Q4
4 quarters
|
|
14
Pfizer
PFE
$168B
| $5.17M | 2.09% |
139,023
| – | – |
2013 Q2
26 quarters
|
|
|
15
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.2M | 1.7% |
106,075
+101,075
| +2,022% | +$1.77M |
2019 Q3
1 quarter
|
|
16
Smith & Wesson
SWBI
$626M
| $3.62M | 1.47% |
507,390
| – | – |
2018 Q1
7 quarters
|
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.49M | 1.42% |
7,815
| – | – |
2017 Q3
9 quarters
|
|
18
JPMorgan Chase
JPM
$899B
| $3.22M | 1.31% |
23,050
| – | – |
2013 Q2
26 quarters
|
|
|
BDSI
19
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $3.19M | 1.29% |
504,607
-12,900
| -2% | -$75.8K |
2018 Q1
7 quarters
|
|
20
AbbVie
ABBV
$505B
| $2.92M | 1.18% |
32,953
| – | – |
2015 Q2
18 quarters
|
|
|
21
Bristol-Myers Squibb
BMY
$124B
| $2.81M | 1.14% |
43,715
+13,847
| +46% | +$793K |
2017 Q1
11 quarters
|
|
|
FNM.PRP
22
DELISTED
Federal National Mortgage Association Non Cum Pfd Ser P
FNM.PRP
| $2.67M | 1.08% |
254,559
+204,839
| +412% | +$2.15M |
2019 Q3
1 quarter
|
|
23
Xenon Pharmaceuticals
XENE
$3.26B
| $2.56M | 1.04% |
195,657
+8,346
| +4% | +$87.8K |
2017 Q3
9 quarters
|
|
|
HZNP
24
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.2M | 0.89% |
60,856
-3,508
| -5% | -$108K |
2018 Q2
6 quarters
|
|
|
AIMT
25
DELISTED
Aimmune Therapeutics
AIMT
| $1.87M | 0.76% |
55,990
| – | – |
2017 Q3
9 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2019 Portfolio in Review
As of Q4 2019, David M. Knott held 128 positions worth $247M, up 3.6% from $238M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
David M. Knott withdrew a net $21.9M in Q4 2019, closing 14 positions and reducing 12 holdings. Its most notable exit was Delta Air Lines, an estimated $3.31M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Industrials and Financials.
Against the trend, David M. Knott opened a new position in FANNIE MAE VAR RT PFD SR F worth $1.51M.
- David M. Knott's largest Q4 2019 buy was FANNIE MAE VAR RT PFD SR F: 81,890 shares worth $1.51M.
- David M. Knott added most to Federal National Mortgage Association Non Cum Pfd Ser P in Q4 2019, an estimated $2.15M increase.
- David M. Knott's biggest Q4 2019 reduction was The Stars Group Inc., cutting an estimated $6.62M.
- David M. Knott fully exited Delta Air Lines in Q4 2019, selling an estimated $3.31M.
- David M. Knott's ten largest holdings make up 58% of its $247M portfolio in Q4 2019.
- David M. Knott opened 9 new positions and closed 14 in Q4 2019.
- David M. Knott's portfolio value rose 3.6% quarter-over-quarter to $247M.
Based on David M. Knott's 13F filing for Q4 2019, filed 14 Feb 2020.